Patents by Inventor Samuel Tahmasian

Samuel Tahmasian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11738202
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: August 29, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Samuel Tahmasian
  • Publication number: 20210236830
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 5, 2021
    Inventor: Samuel Tahmasian
  • Patent number: 11000688
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: May 11, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Samuel Tahmasian
  • Patent number: 10857366
    Abstract: A holder for an implantable medical device (IMD) is disclosed. The holder is configured to hold the IMD in a single, operational orientation when the holder containing the IMD is implanted in a patient. The holder is designed to prevent the IMD from moving within the patient and shifting orientation. The holder may have an opening for receiving a connecting pin, for stimulating electrodes, for example, in a mating orientation with respect to a receptacle contained within the IMD. According to some embodiments, the IMD features a metal housing that can serve as an electrode and the holder is configured with a window to allow a portion of the housing to electrically contact flesh of a patient during operation. Holders for containing a single IMD and holders for containing multiple IMDs are disclosed. Holders for containing multiple IMDs are configured to maintain alignment of the IMDs with respect to each other, for example, a parallel alignment.
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: December 8, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Matthew Lee McDonald, Jillian Doubek, Samuel Tahmasian
  • Publication number: 20190290917
    Abstract: A holder for an implantable medical device (IMD) is disclosed. The holder is configured to hold the IMD in a single, operational orientation when the holder containing the IMD is implanted in a patient. The holder is designed to prevent the IMD from moving within the patient and shifting orientation. The holder may have an opening for receiving a connecting pin, for stimulating electrodes, for example, in a mating orientation with respect to a receptacle contained within the IMB. According to some embodiments, the IMB features a metal housing that can serve as an electrode and the holder is configured with a window to allow a portion of the housing to electrically contact flesh of a patient during operation. Holders for containing a single IMD and holders for containing multiple IMDs are disclosed. Holders for containing multiple IMDs are configured to maintain alignment of the IMDs with respect to each other, for example, a parallel alignment.
    Type: Application
    Filed: June 13, 2019
    Publication date: September 26, 2019
    Inventors: Matthew Lee McDonald, Jillian Doubek, Samuel Tahmasian
  • Patent number: 10335602
    Abstract: A holder for an implantable medical device (IMD) is disclosed. The holder is configured to hold the IMD in a single, operational orientation when the holder containing the IMD is implanted in a patient. The holder is designed to prevent the IMD from moving within the patient and shifting orientation. The holder may have an opening for receiving a connecting pin, for stimulating electrodes, for example, in a mating orientation with respect to a receptacle contained within the IMB. According to some embodiments, the IMB features a metal housing that can serve as an electrode and the holder is configured with a window to allow a portion of the housing to electrically contact flesh of a patient during operation. Holders for containing a single IMD and holders for containing multiple IMDs are disclosed. Holders for containing multiple IMDs are configured to maintain alignment of the IMDs with respect to each other, for example, a parallel alignment.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: July 2, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Matthew Lee McDonald, Jillian Doubek, Samuel Tahmasian
  • Publication number: 20180272144
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Application
    Filed: June 1, 2018
    Publication date: September 27, 2018
    Inventor: Samuel Tahmasian
  • Publication number: 20180272134
    Abstract: An implantable pulse generator (IPG) is disclosed herein. The IPG includes two or more body-mounted electrodes that can be independently programmed to provide stimulation at the location of implantation. The IPG also includes connectors for connecting one or more leads configured with electrode arrays for providing stimulation remote from the IPG. The IPG can be implanted at one location in a patient's body where stimulation is to be delivered and the one or more remote leads can be implanted in additional locations. The disclosed IPG with both body-mounted and remote electrodes reduces the charging complexity of having two microstimulators implanted. The remote lead(s) may be either permanently attached to the IPG or may be removeably attached.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 27, 2018
    Inventors: Samuel Tahmasian, Matthew Lee McDonald, William Morgan, Rafael Carbunaru, Jillian Doubek
  • Publication number: 20180272138
    Abstract: An implantable pulse generator (IPG) is disclosed herein. The IPG may be very small compared to most IPGs and may have a volume on the order of about 3 cm3. The IPG has a separate battery compartment and electronics compartment that may be joined together by laser welding, for example. The combined battery compartment/electronics compartment is then enclosed or partially enclosed within a rigid shell made of a polymeric material. The shell provides structural stability and support for the IPG and provides a barrier against puncturing the IPG. The IPG can then be overmolded with a soft coating material such as silicone. The overmolding provides an additional layer of protection against leakage of non-biocompatible components and also enhances the comfort of the IPG. An electrode assembly may be joined to the IPG prior to overmolding, in which case the overmolding secures the electrode assembly to the IPG.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 27, 2018
    Inventors: Samuel Tahmasian, Matthew Lee McDonald, William Morgan, Rafael Carbunaru, Jillian Doubek
  • Patent number: 10004909
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: June 26, 2018
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Samuel Tahmasian
  • Publication number: 20180015289
    Abstract: A holder for an implantable medical device (IMD) is disclosed. The holder is configured to hold the IMD in a single, operational orientation when the holder containing the IMD is implanted in a patient. The holder is designed to prevent the IMD from moving within the patient and shifting orientation. The holder may have an opening for receiving a connecting pin, for stimulating electrodes, for example, in a mating orientation with respect to a receptacle contained within the IMB. According to some embodiments, the IMB features a metal housing that can serve as an electrode and the holder is configured with a window to allow a portion of the housing to electrically contact flesh of a patient during operation. Holders for containing a single IMD and holders for containing multiple IMDs are disclosed. Holders for containing multiple IMDs are configured to maintain alignment of the IMDs with respect to each other, for example, a parallel alignment.
    Type: Application
    Filed: June 23, 2017
    Publication date: January 18, 2018
    Inventors: Matthew Lee McDonald, Jillian Doubek, Samuel Tahmasian
  • Publication number: 20170326375
    Abstract: Implantable medical device system configured to use removable memory media or wireless communication to avoid having to store charging and other data on the implantable device itself. Some examples include systems of external devices such as an external charger, external patient controller, and/or clinician programmer, that communicate with one another the details of a given implantable device operation using removable memory such as a USB memory drive.
    Type: Application
    Filed: May 15, 2017
    Publication date: November 16, 2017
    Applicant: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: MATTHEW L. MCDONALD, SAMUEL TAHMASIAN, JILLIAN DOUBEK
  • Publication number: 20160367827
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Application
    Filed: August 31, 2016
    Publication date: December 22, 2016
    Inventor: Samuel Tahmasian
  • Patent number: 9433796
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: September 6, 2016
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Samuel Tahmasian
  • Patent number: 9149643
    Abstract: A communications bridge device communicates between a consumer electronics device, such as a smart telephone, and an implantable medical device. The bridge forwards instructions and data between the consumer electronics device and the implantable medical device. The bridge contains a first transceiver that operates according to a communication protocol operating in the consumer electronics device (such as Bluetooth®), and second transceiver that operates according to a communications technique operating in the implantable medical device (e.g., Frequency Shift Keying). A software application is installed on the consumer electronics device, which provides a user interface for controlling and reading the implantable medical device. The software application is downloadable using standard cellular means. The bridge is preferably small, and easily and discreetly carried by the implantable medical device patient.
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: October 6, 2015
    Assignee: Boston Scientific Neuromodualtion Corporation
    Inventors: Samuel Tahmasian, Daniel Aghassian, Douglas Michael Ackermann, Joonho Hyun, Dennis Ralph Zottola
  • Publication number: 20150182754
    Abstract: A communications bridge device communicates between a consumer electronics device, such as a smart telephone, and an implantable medical device. The bridge forwards instructions and data between the consumer electronics device and the implantable medical device. The bridge contains a first transceiver that operates according to a communication protocol operating in the consumer electronics device (such as Bluetooth®), and second transceiver that operates according to a communications technique operating in the implantable medical device (e.g., Frequency Shift Keying). A software application is installed on the consumer electronics device, which provides a user interface for controlling and reading the implantable medical device. The software application is downloadable using standard cellular means. The bridge is preferably small, and easily and discreetly carried by the implantable medical device patient.
    Type: Application
    Filed: March 16, 2015
    Publication date: July 2, 2015
    Inventors: Samuel Tahmasian, Daniel Aghassian, Douglas Michael Ackermann, Joonho Hyun, Dennis Ralph Zottola
  • Patent number: 9067072
    Abstract: Two LC circuits (each with its own coil) are used in either or both of an external controller or an implanted medical device to extend the range at which the two devices can communicate. Only one of the LC circuits (i.e., one of the coils) is used when the device is transmitting, while both LC circuits (i.e., both coils) are used when the device is receiving. When receiving, the LC circuits are preferably connected in series. The series connection of the LC circuits does not affect the resonant frequency, and thus this resonant frequency is the same for both transmission and reception despite the different LC circuits used. Switching circuitry is controlled to disconnect one of the LC circuits when the device is transmitting, and to connect the LC circuits in series during reception.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: June 30, 2015
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Samuel Tahmasian, Tom Stouffer
  • Patent number: 8983615
    Abstract: A communications bridge device communicates between a consumer electronics device, such as a smart telephone, and an implantable medical device. The bridge forwards instructions and data between the consumer electronics device and the implantable medical device. The bridge contains a first transceiver that operates according to a communication protocol operating in the consumer electronics device (such as Bluetooth®), and second transceiver that operates according to a communications technique operating in the implantable medical device (e.g., Frequency Shift Keying). A software application is installed on the consumer electronics device, which provides a user interface for controlling and reading the implantable medical device. The software application is downloadable using standard cellular means. The bridge is preferably small, and easily and discreetly carried by the implantable medical device patient.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: March 17, 2015
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Samuel Tahmasian, Daniel Ahassian, Douglas Michael Ackermann, Joonho Hyun, Dennis Ralph Zottola
  • Publication number: 20150066110
    Abstract: A Medical Device Application (MDA) is disclosed for an external device (e.g., a cell phone) that can communicate with an Implantable Medical Device (IMD). The MDA receives data logged in the IMD, processes that data in manners reviewable by an IMD patient, and that can control the IMD based on such processed data. The MDA can use the logged data to adjust IMD therapy based on patient activity or posture, and allows a patient to learn optimal therapy settings for particular activities. The MDA can also use the logged data to allow a patient to review details about IMD battery performance, whether such battery is primary or rechargeable, and to control stimulation parameters based on that performance. The MDA also allows a patient to enter medicine dose information, to review the relationship between medicinal therapy and IMD therapy, and to adjust IMD therapy based on the dosing information.
    Type: Application
    Filed: September 3, 2014
    Publication date: March 5, 2015
    Inventor: Samuel Tahmasian
  • Publication number: 20140257432
    Abstract: Two LC circuits (each with its own coil) are used in either or both of an external controller or an implanted medical device to extend the range at which the two devices can communicate. Only one of the LC circuits (i.e., one of the coils) is used when the device is transmitting, while both LC circuits (i.e., both coils) are used when the device is receiving. When receiving, the LC circuits are preferably connected in series. The series connection of the LC circuits does not affect the resonant frequency, and thus this resonant frequency is the same for both transmission and reception despite the different LC circuits used. Switching circuitry is controlled to disconnect one of the LC circuits when the device is transmitting, and to connect the LC circuits in series during reception.
    Type: Application
    Filed: November 12, 2013
    Publication date: September 11, 2014
    Applicant: Boston Scientific Neuromodulation Corporation
    Inventors: Samuel Tahmasian, Tom Stouffer